News From Industry Sources
Tennis elbow sufferers find relief with ForeArmed® Active Implant Brace
June 23, 2008
The BioBrace company’s, ForeArmed® Active Implant Brace, which uses the ancient art of acupressure and combines it with 21st Century biomechanics technology, offers a solution for tennis elbow sufferers in the company’s. Story
Acurox tablets meet primary endpoint in pivotal phase III study
June 17, 2008
Opioid With a Unique Composition of Ingredients Intended to Deter Common Methods of Prescription Drug Abuse. Both strengths of Acurox(tm) Tablets met the primary pain relief endpoint compared to placebo (p=.0001, and p less than.0001). The most prevalent reported adverse events in patients receiving Acurox(tm) Tablets were nausea, vomiting, dizziness, pruritis and flushing. Story
FDA approves Cymbalta(R) for the management of fibromyalgia
June 16, 2008
The U.S. Food and Drug Administration has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia Story
Lilly's Cymbalta found to reduce pain severity in osteoarthritis study
June 16, 2008
Eli Lilly and Company has reported positive data which showed that patients with osteoarthritis pain of the knee treated with 60mg and 120mg Cymbalta once daily experienced significant pain reduction. Patients also reported significant pain improvement compared to placebo within the first week of treatment that lasted throughout the 13-week trial. Story
Treating pain effectively - new study results confirm improved gastrointestinal tolerability of tapentadol
June 13, 2008
Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal tolerability as well as safety profile compared to oxycodone HCl IR. Story
Patients taking Cymbalta(R) reported reduced pain severity of osteoarthritis of the knee in new study
June 13, 2008
New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta once daily experienced significant pain reduction. Patients taking Cymbalta reported significant pain improvement compared to placebo within the first week of treatment that lasted throughout the 13- week trial. Story
|
